News Column

Studies from L. Cunha and Colleagues Provide New Data on Drug Development (The role of molecular imaging in modern drug development)

August 18, 2014

By a News Reporter-Staff News Editor at Clinical Trials Week -- Current study results on Drug Development have been published. According to news originating from Oporto, Portugal, by NewsRx correspondents, research stated, "Drug development represents a highly complex, inefficient and costly process."

Our news journalists obtained a quote from the research, "Over the past decade, the widespread use of nuclear imaging, owing to its functional and molecular nature, has proven to be a determinant in improving the efficiency in selecting the candidate drugs that should either be abandoned or moved forward into clinical trials. This helps not only with the development of safer and effective drugs but also with the shortening of time-to-market."

According to the news editors, the research concluded: "The modern concept and future trends concerning molecular imaging will assumedly be hybrid or multimodality imaging, including combinations between high sensitivity and functional (molecular) modalities with high spatial resolution and morphological techniques."

For more information on this research see: The role of molecular imaging in modern drug development. Drug Discovery Today, 2014;19(7):936-948. Drug Discovery Today can be contacted at: Elsevier Sci Ltd, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, Oxon, England. (Elsevier -; Drug Discovery Today -

The news correspondents report that additional information may be obtained from L. Cunha, IsoPor SA, Oporto, Portugal. Additional authors for this research include K. Szigeti, D. Mathe and L.F. Metello (see also Drug Development).

Keywords for this news article include: Oporto, Europe, Therapy, Portugal, Nanotechnology, Drug Development, Molecular Imaging, Emerging Technologies

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Clinical Trials Week

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters